Title : Amyloid Beta Peptide (Aβ1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release.

Pub. Date : 2020 Sep 7

PMID : 32906646






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Abeta1-42 dose-dependently (IC50 = 2.54 microM) reversed the inhibitory effect of canonical and non-canonical nicotinic agonists on BzATP-mediated IL-1beta-release by monocytic cells, whereas reverse Abeta42-1 was ineffective. 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate interleukin 1 alpha Homo sapiens